About Altacor Pharma
Altacor Pharma is a company based in Cambridge (United Kingdom) founded in 2006 was acquired by Fidia Farma in September 2025. Altacor Pharma has raised $3.06 million across 2 funding rounds from investors including Fidia Farma, Enterprise Ventures and Clive Austin. Altacor Pharma offers products and services including Clinitas Drops, Clinitas Gel, BioLon, and Clinitas Antibacterial Eye Compress. Altacor Pharma operates in a competitive market with competitors including Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others.
- Headquarter Cambridge, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Altacor Limited
- Date of Incorporation 12 Apr, 2005
- Jurisdiction WINDSOR, BERKSHIRE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.06 M (USD)
in 2 rounds
-
Latest Funding Round
$3.06 M (USD), Series A
Feb 08, 2011
-
Investors
Fidia Farma
& 4 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Altacor Pharma
Altacor Pharma offers a comprehensive portfolio of products and services, including Clinitas Drops, Clinitas Gel, BioLon, and Clinitas Antibacterial Eye Compress.
Provides relief for dry eye conditions through lubricating drops.
Offers hydration for severe dry eye symptoms.
Used as viscoelastic device in ophthalmic surgery procedures.
Helps alleviate symptoms of blepharitis and eye irritation.
Funding Insights of Altacor Pharma
Altacor Pharma has successfully raised a total of $3.06M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.06 million completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Altacor Pharma
Altacor Pharma has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Fidia Farma, Enterprise Ventures and Clive Austin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early and Growth stage Venture Debt firm that does debt investments in the UK
|
Locked | Locked | Locked | |
|
Tax-efficient investment opportunities are provided by ProVen for retail investors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Altacor Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Altacor Pharma
Investment portfolio details for Altacor Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Altacor Pharma
Detailed financials for Altacor Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Altacor Pharma Comparisons
Peer comparison for Altacor Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Altacor Pharma
Altacor Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| Locked | Locked | Locked |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| Locked | Locked | Locked |
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
|
| Locked | Locked | Locked |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| Locked | Locked | Locked |
Mobile SDK developed for app engagement and monetization strategies.
|
|
| Locked | Locked | Locked |
Gene therapies for ocular and neurodegenerative diseases are developed.
|
Detailed competitors of Altacor Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Altacor Pharma
Complete news archive for Altacor Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Altacor Pharma
Altacor Pharma was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Altacor Pharma is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Altacor Pharma is a funded company, having raised a total of $3.06M across 2 funding rounds to date.
Altacor develops ophthalmic products for dry-eye, glaucoma, glaucoma surgery and ocular surgery. Products include clinitas and clinitas GEL, prescription products for the treatment of moderate dry eye; Clinitas Range, for treating major causes of dry eye; Blepharitis Range loosens and removes Meibomian secretions; and Ocular supplements like EyeBar, a chocolate bar containing AREDS2 formula for the maintenance of healthy vision. The companys RD pipeline covers products for eye surgery and glaucoma. The company was acquired by Esperante in 2014.
Altacor Pharma's top competitors include Annexon, Alimera Sciences and MeiraGTx.
Altacor Pharma offers Clinitas Drops, Clinitas Gel, BioLon, and Clinitas Antibacterial Eye Compress.
Altacor Pharma has 5 investors. Key investors include Fidia Farma, Enterprise Ventures, Clive Austin, ProVen, and Esperante.